Everolimus-eluting Bioresorbable Vascular Scaffold Implantation in Real World and Complex Coronary Disease: Procedural and 30-day Outcomes at Two Australian Centres

Heart, Lung & Circulation
Daniel RobaeiN Jepson

Abstract

The Absorb BVS is a new generation of coronary stent designed to provide coronary arteries with mechanical support of a temporary nature, following balloon angioplasty. Clinical trials of the device have shown promising results thus far, however concern surrounds the deliverability of the device in real-world and complex coronary disease, and the possible higher incidence of early scaffold thrombosis when compared to conventional metallic drug-eluting stents. Implantation of the Absorb BVS was attempted in 152 lesions in 100 patients at two Sydney teaching hospitals, as part of a prospective registry. Lesions treated reflected a wide spectrum of real-world disease. Young patient age, long lesion length and involvement of the mid-portion of the left anterior descending artery were the strongest factors likely to influence the decision to use the Absorb BVS over conventional metallic stents. There were no restrictions on the lesion length, or on the number of lesions or vessels treated. Type C lesions made up 37% of all lesions treated with 64% of these being long lesions (>20mm). The Absorb BVS was successfully implanted in 98.8% of cases. Post-dilatation was performed in 95% of scaffolds. Peri-procedural non-ST elevation myocar...Continue Reading

References

May 2, 2007·Circulation·Donald E CutlipUNKNOWN Academic Research Consortium
Dec 25, 2009·Circulation. Cardiovascular Interventions·John A Ormiston, Patrick W S Serruys
Oct 5, 2010·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Yosinobu OnumaRichard Rapoza
Sep 11, 2012·Journal of the American College of Cardiology·Kristian ThygesenDaniel R Wagner
Jan 18, 2013·Clinical Chemistry·Allan S Jaffe, Fred S Apple
Jan 24, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Yoshinobu OnumaUNKNOWN SPIRIT II Investigators
Feb 22, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Patrick W Serruys
Mar 30, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Michael MagroRobert-Jan van Geuns
May 21, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Paul Jau Lueng OngHee Hwa Ho
Sep 4, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Cihan SimsekRobert-Jan van Geuns
Sep 4, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Tommaso GoriThomas Münzel
Dec 3, 2013·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Patrick W SerruysJohn A Ormiston
Jul 22, 2014·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·Davide CapodannoCorrado Tamburino
Dec 1, 2012·Global Heart·Kristian ThygesenHarvey D White

❮ Previous
Next ❯

Citations

Oct 17, 2015·Journal of the American College of Cardiology·Runlin GaoUNKNOWN ABSORB China Investigators
May 21, 2016·JACC. Cardiovascular Interventions·Hiroyoshi KawamotoAntonio Colombo
Nov 21, 2016·EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology·José de Ribamar CostaPatrick W Serruys
Sep 16, 2016·The Medical Journal of Australia·Daniel Chen, Nigel Jepson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Tommaso GoriThomas Münzel
EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Robin P KraakJoanna J Wykrzykowska
Postępy w kardiologii interwencyjnej = Advances in interventional cardiology
Juan Carlos Rama-MerchanCarlo Di Mario
EuroIntervention : Journal of EuroPCR in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Jochen WöhrleDetlef G Mathey
© 2021 Meta ULC. All rights reserved